Literature DB >> 26878562

Pre-existing diabetes in pregnancy.

Suja Padmanabhan1, Monica Zen, Vincent Lee, Ngai Wah Cheung.   

Abstract

The incidence of type 1 and type 2 diabetes amongst women of reproductive age is increasing worldwide. Despite recent advances in treatment options for diabetes outside of pregnancy, women still have a significantly increased risk of adverse obstetric outcomes including perinatal death and congenital malformation, compared to the non-diabetic population. An understanding of the physiological changes during pregnancy, management, early detection and prevention of complications and pre-pregnancy care, specific to women with pre-existing diabetes, is important in improving health outcomes in this growing group of women. This review particularly focuses on areas where there have been recent developments or controversy.

Entities:  

Mesh:

Year:  2016        PMID: 26878562

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  4 in total

1.  Mild periconceptional hyperglycemia: predictor of adverse fetomaternal outcomes in gestational diabetes?

Authors:  M Saraiva; L Fonseca; T Santos; J Vilaverde; M T Pereira; F Pichel; C Pinto; M C Almeida; J Dores
Journal:  Acta Diabetol       Date:  2021-04-15       Impact factor: 4.280

2.  Association of Maternal Prepregnancy Diabetes and Gestational Diabetes Mellitus With Congenital Anomalies of the Newborn.

Authors:  Yuxiao Wu; Buyun Liu; Yangbo Sun; Yang Du; Mark K Santillan; Donna A Santillan; Linda G Snetselaar; Wei Bao
Journal:  Diabetes Care       Date:  2020-10-21       Impact factor: 19.112

3.  Effects of pre-gestational diabetes mellitus and gestational diabetes mellitus on macrosomia and birth defects in Upstate New York.

Authors:  Guang-Ran Yang; Timothy D Dye; Dongmei Li
Journal:  Diabetes Res Clin Pract       Date:  2019-08-08       Impact factor: 5.602

Review 4.  Metformin in the management of diabetes during pregnancy and lactation.

Authors:  Gagan Priya; Sanjay Kalra
Journal:  Drugs Context       Date:  2018-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.